Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.verified

OPNT

Price:

$20.65

Market Cap:

$108.80M

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Industry

Biotechnology

IPO Date

2007-06-04

Stock Exchange

NASDAQ

Ticker

OPNT

The PE Ratio as of November 2025 (TTM) for Opiant Pharmaceuticals, Inc. (OPNT) is -3.16

According to Opiant Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.16. This represents a change of -128.13% compared to the average of 11.24 of the last 4 quarters.

Opiant Pharmaceuticals, Inc. (OPNT) Historical PE Ratio (quarterly & annually)

How has OPNT PE Ratio performed in the past?

The mean historical PE Ratio of Opiant Pharmaceuticals, Inc. over the last ten years is 1.40. The current -3.16 PE Ratio has changed -22725.43% with respect to the historical average. Over the past ten years (40 quarters), OPNT's PE Ratio was at its highest in in the December 2021 quarter at 49.80. The PE Ratio was at its lowest in in the June 2020 quarter at -44.50.

Quarterly (TTM)
Annual

Average

1.40

Median

-3.26

Minimum

-18.34

Maximum

49.80

Opiant Pharmaceuticals, Inc. (OPNT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Opiant Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 267.76%

Maximum Annual PE Ratio = 49.80

Minimum Annual Increase = -467.44%

Minimum Annual PE Ratio = -18.34

Quarterly (TTM)
Annual
YearPE RatioChange
202149.80-371.58%
2020-18.34-467.44%
20194.99-345.24%
2018-2.04-124.04%
20178.47-225.26%
2016-6.76-5.11%
2015-7.1269.22%
2014-4.21-50.52%
2013-8.51267.76%
2012-2.3117.52%

Opiant Pharmaceuticals, Inc. (OPNT) Average PE Ratio

How has OPNT PE Ratio performed in the past?

The current PE Ratio of Opiant Pharmaceuticals, Inc. (OPNT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

12.15

5-year avg

8.58

10-year avg

1.40

Opiant Pharmaceuticals, Inc. (OPNT) PE Ratio vs. Peers

How is OPNT’s PE Ratio compared to its peers?

Opiant Pharmaceuticals, Inc.’s PE Ratio is less than Cyteir Therapeutics, Inc. (-2.42), less than RVL Pharmaceuticals plc (-0.05), less than HilleVax, Inc. (-1.47), greater than Tourmaline Bio, Inc. (-13.97), less than Jounce Therapeutics, Inc. (-1.91), less than Miromatrix Medical Inc. (-2.34), less than Decibel Therapeutics, Inc. (-1.95), greater than Graybug Vision, Inc. (-7478.67), less than Paratek Pharmaceuticals, Inc. (-1.91), greater than Aadi Bioscience, Inc. (-16.98),

Build a custom stock screener for Opiant Pharmaceuticals, Inc. (OPNT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opiant Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opiant Pharmaceuticals, Inc. (OPNT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opiant Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Opiant Pharmaceuticals, Inc.'s PE Ratio?

How is the PE Ratio calculated for Opiant Pharmaceuticals, Inc. (OPNT)?

What is the highest PE Ratio for Opiant Pharmaceuticals, Inc. (OPNT)?

What is the 3-year average PE Ratio for Opiant Pharmaceuticals, Inc. (OPNT)?

What is the 5-year average PE Ratio for Opiant Pharmaceuticals, Inc. (OPNT)?

How does the current PE Ratio for Opiant Pharmaceuticals, Inc. (OPNT) compare to its historical average?